CCLSA - WA CPD Event
Date: 12/11/2024 (AWST)
Venue: UWA Optometry - Seminar Room 39 Fairway, Crawley, WA, 6009
Provider: Cornea & Contact Lens Society of Australia
Contact: Katelyn Seary, [E] info@cclsa.org.au, [P] 02 9431 8676
Activity Outline
To register to attend please go to https://www.cclsa.org.au/news-events/events/.
This event will involve 3 speakers, each with 30 minutes allocated followed a 10-minute interactive session related to their content. In addition, each session will include live polling via a mobile app for participation from the audience. The attendees will be seated at tables with maximum of 6 people per table for the duration of each session. During the Q&A times, we will give time for discussion between attendees to discuss the relevance to their clinical practice.
The first speaker, Dr Emma Gilles will be presenting data from a randomised controlled clinical trial exploring the efficacy of a novel contact lens design for myopia control. In addition, the application of combination therapy with low-dose atropine will be discussed.
2nd, Eric Cheng will demonstrate the use of topography-based GP lens design using specialised software to enhance myopia control in OrthoK. In addition, the application of combination therapy with low-dose atropine will be discussed.
3rd, compounding pharmacist Devesh Sheth will present on the compounding of low-dose atropine for myopia control and other therapeutic ophthalmic preparation. He will detail areas around sterility and bioavailability of compounder therapeutic interventions.
Learning Objectives
- Understand the catenary curve design of NaturalVue Multifocal and its application in the correction of presbyopia and in myopia progression control
- Improve their fitting of presbyopes for first time success
- Understand the efficacy of NaturalVue in Myopia Progression control, the role of pupil size on treatment effect, as well as the potential for enhanced efficacy with combination atropine therapy
- Understand the use of topography-based lens GP design with Wave
- Understand how to modify OrthoK lens design to enhance myopia control outcomes, as well as the potential for enhanced efficacy with combination atropine therapy
- Understand the importance of maintaining sterility during the compounding of ophthalmic therapeutics along with issues around bioavailability in compounded low-dose atropine
Max CPD hours awarded: 2.25
Session Information
| Name |
|---|
| Use of the NaturalVue Multifocal for correction of presbyopia and myopia progression control; including fitting skills and troubleshooting |
| Clinical? |
| Yes |
| Interactive? |
| Yes |
| Therapeutic? |
| No |
| Duration of CPD Session/Module |
| 0.75 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.75 |
| Name |
|---|
| Topography-based custom GP lens design with Wave |
| Clinical? |
| Yes |
| Interactive? |
| Yes |
| Therapeutic? |
| No |
| Duration of CPD Session/Module |
| 0.75 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.75 |
| Name |
|---|
| compounding of low-dose atropine for myopia control & other therapeutic ophthalmic preparations |
| Clinical? |
| Yes |
| Interactive? |
| Yes |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 0.75 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.75 |